Allakos logo
Allakos ALLK

Quarterly report 2025-Q1
added 05-07-2025

report update icon

Allakos Shares 2011-2026 | ALLK

Annual Shares Allakos

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
86.8 M 63.3 M 53.8 M 49.5 M 45.2 M 19.8 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
86.8 M 19.8 M 53.1 M

Quarterly Shares Allakos

2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
89.9 M 89.6 M 89 M 88.6 M 88 M 87.8 M 87.1 M 86.6 M 85.8 M 85.4 M 58.2 M 54.8 M 54.7 M 54.6 M 54.1 M 53.7 M 53.2 M 53.1 M 49 M 48.8 M 48.7 M 48.7 M 46.3 M 43.1 M 42.6 M 42.1 M 32.6 M 2.25 M 2.02 M 2.11 M 1.64 M 1.48 M - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
89.9 M 1.48 M 53.9 M

Shares of other stocks in the Biotechnology industry

Issuer Shares Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
33.4 M - 2.43 % $ 254 M germanyGermany
AbCellera Biologics AbCellera Biologics
ABCL
299 M $ 3.56 2.01 % $ 1.06 B canadaCanada
Acorda Therapeutics Acorda Therapeutics
ACOR
1.24 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
12.1 M - 4.01 % $ 150 M canadaCanada
Advaxis Advaxis
ADXS
6.02 M - -9.65 % $ 45.9 M usaUSA
I-Mab I-Mab
IMAB
187 M - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
78.2 M - - $ 1.01 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
1.08 K - -10.17 % $ 12.2 K usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
5.45 M $ 0.79 -0.79 % $ 4.31 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
219 M - - $ 40.3 B usaUSA
Biophytis SA Biophytis SA
BPTS
118 M - -13.47 % $ 169 M franceFrance
Albireo Pharma Albireo Pharma
ALBO
19.2 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
17.9 M - 10.36 % $ 9.8 M usaUSA
argenx SE argenx SE
ARGX
51.1 M $ 703.3 0.41 % $ 25 B niderlandNiderland
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
4.58 M - -1.52 % $ 24.7 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
54.8 M $ 231.03 2.23 % $ 5 B danmarkDanmark
ADC Therapeutics SA ADC Therapeutics SA
ADCT
76.7 M $ 4.22 2.18 % $ 105 M schweizSchweiz
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
2.41 B $ 3.61 0.28 % $ 8.69 B australiaAustralia
Midatech Pharma plc Midatech Pharma plc
MTP
80.5 M - -18.52 % $ 27.3 M britainBritain
Adverum Biotechnologies Adverum Biotechnologies
ADVM
19.8 M - - $ 86.2 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
45 M - - $ 26.5 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
38.8 M - - $ 10.1 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
27.4 M $ 6.63 -0.75 % $ 182 M israelIsrael
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
75 M - - - russiaRussia
Akero Therapeutics Akero Therapeutics
AKRO
67.1 M - - $ 3.67 B usaUSA
Athersys Athersys
ATHX
224 M - 3.77 % $ 22.4 M usaUSA
Akouos Akouos
AKUS
34.4 M - 0.23 % $ 488 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
15.8 M - 2.71 % $ 14 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
16.8 M - 1052.0 % $ 415 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
68 M - 3.16 % $ 1.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
115 M - 5.93 % $ 314 M canadaCanada
AlloVir AlloVir
ALVR
5.01 M - 4.14 % $ 49.1 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
14.7 M $ 14.36 1.13 % $ 210 M usaUSA
Aptinyx Aptinyx
APTX
67.7 M - -39.0 % $ 4.57 M usaUSA
BioNTech SE BioNTech SE
BNTX
244 M $ 90.54 -0.71 % $ 27.2 B germanyGermany
Aptose Biosciences Aptose Biosciences
APTO
699 K - -45.71 % $ 1.2 M canadaCanada
Burford Capital Limited Burford Capital Limited
BUR
219 M $ 8.05 1.64 % $ 1.31 B britainBritain
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
32.7 M - - $ 521 M usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
81.5 M $ 6.05 -0.82 % $ 493 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
15.4 M - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
6.28 M $ 2.64 3.94 % $ 16.6 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
1.3 M - -52.27 % $ 4.45 M usaUSA
BioCardia BioCardia
BCDA
21.2 M $ 1.27 0.79 % $ 26.9 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
255 M $ 1.51 4.86 % $ 385 M britainBritain
Athira Pharma Athira Pharma
ATHA
38.5 M - - $ 269 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.18 B $ 3.58 -0.56 % $ 7.79 B israelIsrael
CureVac N.V. CureVac N.V.
CVAC
186 M - - $ 867 M germanyGermany
Aravive Aravive
ARAV
36.4 M - -13.39 % $ 1.45 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
1.42 B - - $ 96.9 B britainBritain
Actinium Pharmaceuticals Actinium Pharmaceuticals
ATNM
30.1 M $ 1.11 - $ 33.4 M usaUSA